Back to search

Peptide record

TPDB07442

Antibacterial Antifungal standard
14 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB07442
Antibacterial Antifungal
Anti-infective peptides
AntiBP3 dbAMP DRAMP Peptipedia AFP-GFuse Antifungipept CAFPdb
standard
No
A 14-aa standard natural multi-activity (Antibacterial and Antifungal) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
FDVMGIIKKIAGAL
Physicochemical Analysis
C69H118N16O17S1
RNCEQHPSTWY
I
1475.85
9.88
2
1
9
+1
0.11
1.264
146.43
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
0
0.00
0
Residue Composition
number
2
A
0
R
0
N
1
D
0
C
0
E
0
Q
2
G
0
H
3
I
1
L
2
K
1
M
1
F
0
P
0
S
0
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 2 R: 0 N: 0 D: 1 C: 0 E: 0 Q: 0 G: 2 H: 0 I: 3 L: 1 K: 2 M: 1 F: 1 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 1
Chemical Descriptors
14
C69H118N16O17S1
1475.85
9.88
+1
0.11
1.264
Evidence Records 14 records
Evidence 1 Activity

Activity

MIC
Antibacterial
30 µM

Target

Staphylococcus aureus ATCC 25923

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against Gram+ S. aureus ATCC 25923 (MIC 30 uM), S. epidermidis clinical sample (MIC 30 uM), M. luteus ATCC 10240 (MIC 30 uM), S-pyogenes
Evidence 2 Activity

Activity

MIC
Antibacterial
30 µM

Target

Staphylococcus epidermidis clinical sample

Source & Reference

dbAMP DRAMP

Other

Active against Gram+ S. aureus ATCC 25923 (MIC 30 uM), S. epidermidis clinical sample (MIC 30 uM), M. luteus ATCC 10240 (MIC 30 uM), S-pyogenes clinical sample (MIC >30 uM), B. subtilis A
Evidence 3 Activity

Activity

MIC
Antibacterial
30 µM

Target

M. luteus ATCC 10240

Source & Reference

dbAMP DRAMP

Other

ainst Gram+ S. aureus ATCC 25923 (MIC 30 uM), S. epidermidis clinical sample (MIC 30 uM), M. luteus ATCC 10240 (MIC 30 uM), S-pyogenes clinical sample (MIC >30 uM), B. subtilis ATCC 6633 (MIC 30 uM), Gram- E. col
Evidence 4 Activity

Activity

MIC
Antibacterial
30 µM

Target

B. subtilis ATCC 6633

Source & Reference

dbAMP DRAMP

Other

e (MIC 30 uM), M. luteus ATCC 10240 (MIC 30 uM), S-pyogenes clinical sample (MIC >30 uM), B. subtilis ATCC 6633 (MIC 30 uM), Gram- E. coli ATCC 25922 (MIC 30 uM), P. mirabilis clinical sample (MIC 60 uM), P-aerugi
Evidence 5 Activity

Activity

MIC
Antibacterial
30 µM

Target

Escherichia coli ATCC 25922

Source & Reference

dbAMP DRAMP

Other

30 uM), S-pyogenes clinical sample (MIC >30 uM), B. subtilis ATCC 6633 (MIC 30 uM), Gram- E. coli ATCC 25922 (MIC 30 uM), P. mirabilis clinical sample (MIC 60 uM), P-aeruginosa ATCC 27853 (MIC >30 uM), S-maltop
Evidence 6 Activity

Activity

MIC
Antibacterial
60 µM

Target

P. mirabilis clinical sample

Source & Reference

dbAMP DRAMP

Other

le (MIC >30 uM), B. subtilis ATCC 6633 (MIC 30 uM), Gram- E. coli ATCC 25922 (MIC 30 uM), P. mirabilis clinical sample (MIC 60 uM), P-aeruginosa ATCC 27853 (MIC >30 uM), S-maltophilia ATCC 13637 (MIC >30 uM), yeast C. al
Evidence 7 Activity

Activity

MIC
Antibacterial
7.5 µM

Target

Candida albicans ATCC 90112

Source & Reference

dbAMP DRAMP

Other

0 uM), P-aeruginosa ATCC 27853 (MIC >30 uM), S-maltophilia ATCC 13637 (MIC >30 uM), yeast C. albicans ATCC 90112 (MIC 7.5 uM),
Evidence 8 Activity

Activity

MIC
Antifungal
30 µM

Target

Staphylococcus aureus ATCC 25923

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against Gram+ S. aureus ATCC 25923 (MIC 30 uM), S. epidermidis clinical sample (MIC 30 uM), M. luteus ATCC 10240 (MIC 30 uM), S-pyogenes
Evidence 9 Activity

Activity

MIC
Antifungal
30 µM

Target

Staphylococcus epidermidis clinical sample

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against Gram+ S. aureus ATCC 25923 (MIC 30 uM), S. epidermidis clinical sample (MIC 30 uM), M. luteus ATCC 10240 (MIC 30 uM), S-pyogenes clinical sample (MIC >30 uM), B. subtilis A
Evidence 10 Activity

Activity

MIC
Antifungal
30 µM

Target

M. luteus ATCC 10240

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

ainst Gram+ S. aureus ATCC 25923 (MIC 30 uM), S. epidermidis clinical sample (MIC 30 uM), M. luteus ATCC 10240 (MIC 30 uM), S-pyogenes clinical sample (MIC >30 uM), B. subtilis ATCC 6633 (MIC 30 uM), Gram- E. col
Evidence 11 Activity

Activity

MIC
Antifungal
30 µM

Target

B. subtilis ATCC 6633

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

e (MIC 30 uM), M. luteus ATCC 10240 (MIC 30 uM), S-pyogenes clinical sample (MIC >30 uM), B. subtilis ATCC 6633 (MIC 30 uM), Gram- E. coli ATCC 25922 (MIC 30 uM), P. mirabilis clinical sample (MIC 60 uM), P-aerugi
Evidence 12 Activity

Activity

MIC
Antifungal
30 µM

Target

Escherichia coli ATCC 25922

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

30 uM), S-pyogenes clinical sample (MIC >30 uM), B. subtilis ATCC 6633 (MIC 30 uM), Gram- E. coli ATCC 25922 (MIC 30 uM), P. mirabilis clinical sample (MIC 60 uM), P-aeruginosa ATCC 27853 (MIC >30 uM), S-maltop
Evidence 13 Activity

Activity

MIC
Antifungal
60 µM

Target

P. mirabilis clinical sample

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

le (MIC >30 uM), B. subtilis ATCC 6633 (MIC 30 uM), Gram- E. coli ATCC 25922 (MIC 30 uM), P. mirabilis clinical sample (MIC 60 uM), P-aeruginosa ATCC 27853 (MIC >30 uM), S-maltophilia ATCC 13637 (MIC >30 uM), yeast C. al
Evidence 14 Activity

Activity

MIC
Antifungal
7.5 µM

Target

Candida albicans ATCC 90112

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

0 uM), P-aeruginosa ATCC 27853 (MIC >30 uM), S-maltophilia ATCC 13637 (MIC >30 uM), yeast C. albicans ATCC 90112 (MIC 7.5 uM),